Literature DB >> 3007608

Tumor necrosis factor induction by Sendai virus.

D Aderka, H Holtmann, L Toker, T Hahn, D Wallach.   

Abstract

Supernatants of peripheral blood mononuclear leukocytes (PBMC) treated with Sendai virus were found to exert significant cytotoxic effects mediated by leukocyte-produced proteins distinct from interferon. Fractionation of the PBMC into adherent and nonadherent cells indicated that these virus-induced cytotoxins (CTX) were produced primarily in the mononuclear phagocytes. Cells of the monocyte-like U937 line pretreated with 4 beta-phorbol-12-myristate-13-acetate could also be induced with Sendai virus to produce CTX. The nonadherent mononuclear cells of the peripheral blood responded poorly to the virus with regard to CTX production, even though they could be induced to produce CTX with phytohemagglutinin (PHA). With the use of monospecific antibodies to tumor necrosis factor (TNF) and to lymphotoxin (LT), it was found that TNF is the major CTX produced by PBMC and by the U937 cells after 24 hr stimulation by the virus, whereas LT is not induced under these conditions to any measurable extent. TNF was also found to be produced in significant amounts together with LT upon stimulation of the nonadherent fraction of the PBMC by PHA. These findings indicate that besides bacterial lipopolysaccharides, other biological agents including viruses can be effective inducers of tumor necrosis factor, suggesting implications regarding the physiologic role of this protein.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3007608

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  Tumour necrosis factor triggers granulocytes to internalize complement-coated virus particles.

Authors:  J A van Strijp; M E van der Tol; L A Miltenburg; K P van Kessel; J Verhoef
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

Review 2.  Regulation of tumor necrosis factor production by monocyte-macrophages and lymphocytes.

Authors:  G Trinchieri
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Cytokine regulation by virus infection: bovine viral diarrhea virus, a flavivirus, downregulates production of tumor necrosis factor alpha in macrophages in vitro.

Authors:  H Adler; T W Jungi; H Pfister; M Strasser; M Sileghem; E Peterhans
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

4.  Beta interferon subtype 1 induction by tumor necrosis factor.

Authors:  H Jacobsen; J Mestan; S Mittnacht; C W Dieffenbach
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

5.  Alveolar macrophages in AIDS patients: increased spontaneous tumour necrosis factor-alpha production in Pneumocystis carinii pneumonia.

Authors:  V L Krishnan; A Meager; D M Mitchell; A J Pinching
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

6.  A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia.

Authors:  H S Ginsberg; L L Moldawer; P B Sehgal; M Redington; P L Kilian; R M Chanock; G A Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

Review 7.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

8.  Parvoviruses are inefficient in inducing interferon-beta, tumor necrosis factor-alpha, or interleukin-6 in mammalian cells.

Authors:  J R Schlehofer; M Rentrop; D N Männel
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

9.  Engagement of tumor necrosis factor mRNA by an endotoxin-inducible cytoplasmic protein.

Authors:  C Gueydan; L Houzet; A Marchant; A Sels; G Huez; V Kruys
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

10.  Human immunodeficiency virus-1 infection of macrophages in vitro neither induces tumor necrosis factor (TNF)/cachectin gene expression nor alters TNF/cachectin induction by lipopolysaccharide.

Authors:  J R Munis; D D Richman; R S Kornbluth
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.